BR112016014981A2 - Acelerador de produção de catecolamina e agente preventivo e terapêutico e composição alimentícia preventiva e terapêutica para doenças causadas por deficiência de catecolamina - Google Patents

Acelerador de produção de catecolamina e agente preventivo e terapêutico e composição alimentícia preventiva e terapêutica para doenças causadas por deficiência de catecolamina

Info

Publication number
BR112016014981A2
BR112016014981A2 BR112016014981A BR112016014981A BR112016014981A2 BR 112016014981 A2 BR112016014981 A2 BR 112016014981A2 BR 112016014981 A BR112016014981 A BR 112016014981A BR 112016014981 A BR112016014981 A BR 112016014981A BR 112016014981 A2 BR112016014981 A2 BR 112016014981A2
Authority
BR
Brazil
Prior art keywords
catecholamine
preventive
deficiency
diseases caused
therapeutic
Prior art date
Application number
BR112016014981A
Other languages
English (en)
Other versions
BR112016014981B1 (pt
Inventor
Okamoto Takeshi
Nemoto Takayuki
Ishii Yoichi
Original Assignee
Well Stone Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Well Stone Co filed Critical Well Stone Co
Publication of BR112016014981A2 publication Critical patent/BR112016014981A2/pt
Publication of BR112016014981B1 publication Critical patent/BR112016014981B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/204—Animal extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

ACELERADOR DE PRODUÇÃO DE CATECOLAMINA E AGENTE PREVENTIVO E TERAPÊUTICO E COMPOSIÇÃO ALIMENTÍCIA PREVENTIVA E TERAPÊUTICA PARA DOENÇAS CAUSADAS POR DEFICIÊNCIA DE CATECOLAMINA, sendo um objetivo da presente invenção é fornecer um acelerador de produção de catecolamina que compreende um produto natural como um ingrediente ativo; um agente terapêutico e agente preventivo para doenças causadas por deficiência de catecolamina; e composições alimentícias para o tratamento ou prevenção de doenças causadas por deficiência de catecolamina, sendo que são fornecidos: um acelerador de produção de catecolamina que compreende um pó seco, um produto moído e/ou um extrato de uma minhoca como um ingrediente ativo; um agente terapêutico e um agente preventivo para uma doença causada por deficiência de catecolamina; e composições alimentícias para o tratamento ou prevenção de uma doença causada por deficiência de catecolamina, preferencialmente selecionada a partir do grupo que consiste em doença de Alzheimer e doença de Parkinson.
BR112016014981-5A 2014-01-20 2015-01-13 Acelerador de produção de catecolamina e agente preventivo e terapêutico e composição alimentícia preventiva e terapêutica para doenças causadas por deficiência de catecolamina BR112016014981B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014-007845 2014-01-20
JP2014007845 2014-01-20
PCT/JP2015/050586 WO2015108014A1 (ja) 2014-01-20 2015-01-13 カテコールアミン産生促進剤、カテコールアミンの欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物

Publications (2)

Publication Number Publication Date
BR112016014981A2 true BR112016014981A2 (pt) 2017-08-08
BR112016014981B1 BR112016014981B1 (pt) 2021-10-13

Family

ID=53542904

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016014981-5A BR112016014981B1 (pt) 2014-01-20 2015-01-13 Acelerador de produção de catecolamina e agente preventivo e terapêutico e composição alimentícia preventiva e terapêutica para doenças causadas por deficiência de catecolamina

Country Status (12)

Country Link
US (1) US10155012B2 (pt)
EP (1) EP3097918B1 (pt)
JP (2) JP6002331B2 (pt)
KR (2) KR101909168B1 (pt)
CN (1) CN106413722B (pt)
AU (1) AU2015207191B2 (pt)
BR (1) BR112016014981B1 (pt)
CA (1) CA2935315C (pt)
PH (1) PH12016501205A1 (pt)
RU (1) RU2708673C2 (pt)
TW (1) TWI679981B (pt)
WO (1) WO2015108014A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6321521B2 (ja) * 2014-11-04 2018-05-09 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物
JP2017025019A (ja) * 2015-07-21 2017-02-02 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 アミロイドβ線維分解剤、アミロイドβの線維化に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物
JP6253837B1 (ja) * 2017-07-18 2017-12-27 エンチーム株式会社 組成物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216572A (ja) * 1983-05-20 1984-12-06 Yoichi Ishii ミミズ蛋白及び脂質健康食品
JPS63238009A (ja) 1987-03-25 1988-10-04 Ichimaru Pharcos Co Ltd ミミズ抽出物含有化粧料
US5024844A (en) * 1987-08-18 1991-06-18 Eimei Company, Ltd. Process for the production of dried earthworm powder and antihyperlipemic, antidiabetic, antihypertensive and antihypotensive preparations containing dried earthworm powder as active ingredient
KR900012617A (ko) 1987-10-28 1990-09-01 요오이찌 이시이 혈전증 치료제 및 그 제조방법
JP2637788B2 (ja) 1988-09-02 1997-08-06 株式会社日立製作所 ディスクキャッシュ制御方式および情報処理システム
JPH02215723A (ja) * 1989-02-15 1990-08-28 Eimei:Kk 血圧調節剤
JPH02215725A (ja) * 1989-02-15 1990-08-28 Eimei:Kk 抗高脂血症剤
JPH02215726A (ja) * 1989-02-15 1990-08-28 Eimei:Kk 糖尿病治療剤
US5186944A (en) * 1989-02-15 1993-02-16 Eimei Company Ltd. Therapeutic medicament for thrombosis
JPH0763564B2 (ja) 1991-11-05 1995-07-12 早川工業株式会社 連続濾過装置
JPH07720A (ja) 1992-02-27 1995-01-06 Sumiko Mayuzumi 濾過装置
JPH07719A (ja) 1993-06-14 1995-01-06 Sochi Maintenance:Kk フィルタプレス用濾布
JPH10259126A (ja) 1997-01-17 1998-09-29 Takeda Chem Ind Ltd アルツハイマー病治療・予防剤
CN1172695C (zh) * 2001-05-22 2004-10-27 周亚滨 一种防治老年痴呆的新药
ITRM20050045A1 (it) * 2005-02-02 2006-08-03 Consiglio Nazionale Ricerche Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi.
CN1873005A (zh) * 2005-06-02 2006-12-06 中国科学院生物物理研究所 蚯蚓微管结合蛋白Tau、其编码基因及其应用
JP4699974B2 (ja) * 2006-09-29 2011-06-15 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 ミミズ乾燥粉末の製造方法
JP5291124B2 (ja) * 2008-01-30 2013-09-18 シン・プーン・ファーマシューティカル・カンパニー・リミテッド 新規なキナゾリン−２，４−ジオン誘導体、及びこれを含有する脳神経系疾患の予防及び治療用医薬組成物
JP4886017B2 (ja) 2009-10-13 2012-02-29 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 ミミズ乾燥粉末の製造方法
KR101198192B1 (ko) * 2011-04-11 2012-11-12 웰 스톤 유겐가이샤 지렁이 건조 분말의 제조 방법
JP4808822B1 (ja) 2011-04-11 2011-11-02 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 ミミズ乾燥粉末の製造方法
JP5856725B2 (ja) * 2011-08-02 2016-02-10 和夫 酒井 うつ病治療用または予防用医薬組成物
CN102675468B (zh) * 2012-01-16 2014-07-30 河南科技大学 一种蚯蚓提取物及其提取方法和应用

Also Published As

Publication number Publication date
EP3097918A1 (en) 2016-11-30
AU2015207191A1 (en) 2016-06-30
US10155012B2 (en) 2018-12-18
RU2708673C2 (ru) 2019-12-11
PH12016501205B1 (en) 2016-08-15
JP6195962B2 (ja) 2017-09-13
JP6002331B2 (ja) 2016-10-05
KR102061183B1 (ko) 2019-12-31
JP2016196516A (ja) 2016-11-24
RU2016133264A3 (pt) 2018-09-27
KR101909168B1 (ko) 2018-10-17
AU2015207191B2 (en) 2020-03-26
KR20180112885A (ko) 2018-10-12
US20160317587A1 (en) 2016-11-03
CA2935315C (en) 2022-07-19
KR20160105906A (ko) 2016-09-07
TW201620532A (zh) 2016-06-16
WO2015108014A1 (ja) 2015-07-23
EP3097918B1 (en) 2019-04-03
CA2935315A1 (en) 2015-07-23
EP3097918A4 (en) 2017-08-30
RU2016133264A (ru) 2018-03-05
CN106413722A (zh) 2017-02-15
JPWO2015108014A1 (ja) 2017-03-23
TWI679981B (zh) 2019-12-21
BR112016014981B1 (pt) 2021-10-13
CN106413722B (zh) 2020-08-04
PH12016501205A1 (en) 2016-08-15

Similar Documents

Publication Publication Date Title
BR112019008458A2 (pt) 1,2,4-triazolonas 2,4,5-trisubstituídas.
BR112017002221A2 (pt) 2-(morfolin-4-il)-1,7-naftiridinas
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
BR112017011923A2 (pt) bactéria modificada para tratar doenças associadas com hiperamonemia
DOP2016000195A (es) Compuestos
TR201910765T4 (tr) Bitkisel hülasaların bir karışımını veya bu bitkilerde mevcut moleküllerin bir karışımını içeren bileşim ve karbonhidrat ve/veya lipit metabolizmasını etkilemek için kullanımı.
BR112016018604A2 (pt) Benzimidazol-2-aminas como inibidores de midh1
BR112017026739A2 (pt) compostos para uso no tratamento de distúrbios neuromusculares
BR112014021104A2 (pt) métodos e composições para o tratamento da doença de huntington
BR112017004704A2 (pt) composto, composição farmacêutica, e, método para tratar uma doença ou distúrbio em um indivíduo
BR112016021648A2 (pt) novos compostos
BR112017006705A2 (pt) inibidores de biossíntese de sulfato de heparan para o tratamento de doenças
MX2018003569A (es) Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos.
BR112019003579A2 (pt) Composições de ribosídeo de nicotinamida e pterostilbeno e métodos para o tratamento dedistúrbios neurodegenerativos
UY36224A (es) Compuestos tricíclicos de imidazo-pirimidinona
BR112017003346B8 (pt) Derivados de pirazolopiridina, seus usos, e composição farmacêutica
CL2018000451A1 (es) Composiciones de micropartículas que comprenden saflufenacil
BR112017026535A2 (pt) composto de fórmula estrutural i, enantiômero isolado, composição farmacêutica, método para inibir atividade do transportador de monocarboxilato mct4, método para inibir seletivamente atividade do transportador de monocarboxilato mct4, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 e uso de um composto
NZ726695A (en) Gls1 inhibitors for treating disease
BR112016017897A8 (pt) uso de composto de carboxamida heterocíclica de diamino no tratamento de câncer relacionado ao axl, composição farmacêutica e combinação
AR108935A1 (es) Extracto de aquenio de silybum marianum y sus usos en dermatología y dermocosmética
MX2018002514A (es) Citotoxinas modificadas y su uso terapeutico.
BR112016021656A2 (pt) inibidores das vias de sinalização de wnt
BR112016014981A2 (pt) Acelerador de produção de catecolamina e agente preventivo e terapêutico e composição alimentícia preventiva e terapêutica para doenças causadas por deficiência de catecolamina
BR112017002260A2 (pt) derivados de piperazina como moduladores do receptor x do fígado

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/01/2015, OBSERVADAS AS CONDICOES LEGAIS.